Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 1/20 | 0.46 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.45 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11469362 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11479558 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11471344 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11472749 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11471431 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL8464105 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11471409 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11485316 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11488575 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 | |
| SCHEMBL11479603 | 1.00 | TBXAS1 (0.46) | TBXAS1EGLN3MEN1KMT2ATLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4160838-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-07-10 | — | — | US | claimed |
| US-4079062-A | ANTIMICROBIAL, PLANT GROWTH REGULATORS; 1-(B-ARYL)ETHYL-1H-1,2,4-TRIAZOLE KETALS | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-03-14 | — | — | US | claimed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20220340577-A1 | GCN2 INHIBITORS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED | 2022-10-27 | — | — | US | disclosed |
| US-10889556-B2 | Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-01-12 | — | — | US | disclosed |
| US-20190106398-A1 | COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-04-11 | — | — | US | disclosed |
| WO-2011035064-A2 | TRIAZOLE CATALYSTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-03-24 | — | — | WO | disclosed |
| US-20080280836-A1 | Anti-hypercholesterolemic biaryl azetidinone compounds | MORRIELLO GREGORI J | 2008-11-13 | — | — | US | disclosed |
| EP-0576201-B1 | Fungicidal 1,2,4-triazoles | ROHM & HAAS (US) | 2001-08-16 | — | — | EP | disclosed |
| EP-0576199-B1 | Fungicidal and herbicidal triazoles | ROHM & HAAS (US) | 2001-08-01 | — | — | EP | disclosed |
| US-5624916-A | Fungicidal 1,2,4-triazoles | ROHM AND HAAS COMPANY (US) | 1997-04-29 | — | — | US | disclosed |
| US-4598085-A | Fungicidal 1-(2-aryl-2-R-ethyl)-1H-1,2,4-triazoles | JANSSEN PHARMACEUTICA N.V. (BE) | 1986-07-01 | — | — | US | disclosed |
| US-4598085-A | Fungicidal 1-(2-aryl-2-R-ethyl)-1H-1,2,4-triazoles | JANSSEN PHARMACEUTICA N.V. (BE) | 1986-07-01 | — | — | US | disclosed |
| US-4556717-A | CATALYTIC HYDROGENATION OF 2-(2,4-DICHLOROPHENYL)-VALERONITRILE | CIBA GEIGY CORPORATION (US) | 1985-12-03 | — | — | US | disclosed |
| US-4479021-A | ESTERIFICATION, PEROXIDATION OF 1-ALKENE WITH FORMIC ACID, AND HYDROGEN PEROXIDE, THEN SAPONIFICATION | CIBA-GEIGY CORPORATION (US) | 1984-10-23 | — | — | US | disclosed |
| EP-0097617-A1 | Method for the production of 1-(2-(,4-dichlorphenyl)pentyl)-1H-1,2,4-triazole and hydrazone- or hydrazine-derivatives | CIBA-GEIGY AG (CH) | 1984-01-04 | — | — | EP | disclosed |
| US-4391813-A | 1-//2-/2,4-DICHLOROPHENYL/-4-ETHYL-1,3-DIOXOLAN-2-YL/METHYL/-1H-1,2,4-TRIAZOLE | CORNELL RESEARCH FOUNDATION, INC. (US) | 1983-07-05 | — | — | US | disclosed |
| US-4220764-A | Preparation of tertiary heterocyclic amines | UOP INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4160838-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-07-10 | — | — | US | disclosed |
| US-4079062-A | ANTIMICROBIAL, PLANT GROWTH REGULATORS; 1-(B-ARYL)ETHYL-1H-1,2,4-TRIAZOLE KETALS | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106398-A1 | COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE | POLRMT, RNASE1, POLM | TBXAS1 1953/4885EGLN3 1862/4885MEN1 3312/4885 |
| US-20080280836-A1 | Anti-hypercholesterolemic biaryl azetidinone compounds | APOB, PCSK9, CYP46A1 | TBXAS1 2138/4885EGLN3 511/4885MEN1 1976/4885 |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | TBXAS1 244/4885EGLN3 1404/4885MEN1 1514/4885 |
| US-20220340577-A1 | GCN2 INHIBITORS AND USES THEREOF | EIF2AK4, GCN1, GCGR | TBXAS1 3413/4885EGLN3 1078/4885MEN1 3168/4885 |
| US-10889556-B2 | Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease | POLRMT, RNASE1, POLM | TBXAS1 1953/4885EGLN3 1862/4885MEN1 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.